Cookson, T. A., Fedorak, R., Halloran, B. P., Dieleman, L. A., Wong, K., Huang, V., . . . Kroeker, K. I. (2018). A157 THE THRESHOLD FOR INFLIXIMAB TROUGH LEVELS LEADING TO DOSE ESCALATION DIFFERS BETWEEN CROHN’S DISEASE AND ULCERATIVE COLITIS. J Can Assoc Gastroenterol.

Cookson, T A., R. Fedorak, B P. Halloran, L A. Dieleman, K. Wong, V. Huang, F. Peerani, et K I. Kroeker. "A157 THE THRESHOLD FOR INFLIXIMAB TROUGH LEVELS LEADING TO DOSE ESCALATION DIFFERS BETWEEN CROHN’S DISEASE AND ULCERATIVE COLITIS." J Can Assoc Gastroenterol 2018.

Cookson, T A., et al. "A157 THE THRESHOLD FOR INFLIXIMAB TROUGH LEVELS LEADING TO DOSE ESCALATION DIFFERS BETWEEN CROHN’S DISEASE AND ULCERATIVE COLITIS." J Can Assoc Gastroenterol 2018.